Larvol Delta - Biomea-Fusion-Presents-Achievement-of-Minimal-Residual-Disease-Negativity-MRDneg-in-First-Complete-Responder-from-Ongoing-Phase-I-Study-COVALENT101-of-BMF219-in-Patients-with-Relapsed-or-Refractory-RR-Acute-Myeloid-Leukemia-AML-at-the-2023-ASH-Annual-Meeting

BMF-219 - Biomea Fusion

https://www.globenewswire.com/news-release/2023/12/11/2793942/0/en/Biomea-Fusion-Presents-Achievement-of-Minimal-Residual-Disease-Negativity-MRD-neg-in-First-Complete-Responder-from-Ongoing-Phase-I-Study-COVALENT-101-of-BMF-219-in-Patients-with-Re.html

Dec 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next